Genetic and molecular analyses of candidate germline BRIP1/FANCJ variants implicated in breast and ovarian cancer
Wejdan M. Alenezi, Larissa Milano, Caitlin T. Fierheller, Corinne Serruya, Timothée Revil, Kathleen Klein Oros, J. J. Bruce, Dan Spiegelman, Trevor J. Pugh, Anne‐Marie Mes‐Masson, Diane Michele Provencher, William David Foulkes, Zaki El Haffaf, Guy Armand Rouleau, Luigi Bouchard, , Patricia N. Tonin
The paper investigates five BRIP1/FANCJ variants for their clinical relevance in breast and ovarian cancer, finding three likely damaging variants associated with cellular sensitivity to chemotherapy drugs.
International Journal of Molecular Sciences · Jan 20, 2026Peer-reviewedGenetic & Genomic Medicine